When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - EC OK's Alexion's Soliris for rare inflammatory disorder
Alexion Pharmaceuticals Inc.
As expected, the European Commission approves Alexion Pharmaceuticals' (NASDAQ:ALXN) Soliris (eculizumab) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody-positive with a relapsing course of the disease.
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news,